Zvese zvawaida Kuziva Nezve SGLT2 Inhibitors

Zvemukati

• Ndeapi marudzi akasiyana eSGLT2 inhibitors?
• Mishonga iyi inotorwa sei?
• Ndeapi mabhenefiti anogona kutora kutora SGLT2 inhibitor?
• Ndedzipi njodzi dzinogona kuitika uye mhedzisiro yekutora mushonga uyu?
• Zvakachengeteka here kusanganisa iyi mhando yemishonga pamwe nezvimwe zvinodhaka?
• Kutora

Mhedziso

SGLT2 inhibitors kirasi yemishonga inoshandiswa kurapa rudzi rwechipiri chirwere cheshuga. Iwo anonziwo sodium-glucose yekufambisa protein 2 inhibitors kana gliflozins.

SGLT2 inhibitors inodzivirira kudzokororwazve kweglucose kubva muropa rakasvinwa kuburikidza neitsvo dzako, nekudaro ichiita kuti kubuda kweglucose mumugini. Izvi zvinobatsira kudzikisa huwandu hweshuga yeropa rako.

Verenga pamusoro kuti udzidze zvakawanda pamusoro pemhando dzakasiyana dzeSGLT2 inhibitors, pamwe nezvinobatsira uye njodzi dzekuwedzera rudzi urwu rwemishonga kuchirongwa chako chekurapa.

Ndeapi marudzi akasiyana eSGLT2 inhibitors?

Parizvino, iyo US Chikafu neDrug Administration (FDA) yakabvumidza ina mhando dzeSGLT2 inhibitors yekurapa rudzi rwechipiri chirwere cheshuga:

• canagliflozin (Invokana)
• dapagliflozin (Farxiga)
• empagliflozin (Jardiance)
• ertugliflozin (Steglatro)

Dzimwe mhando dzeSGLT2 inhibitors dziri kuvandudzwa uye kuyedzwa mumakiriniki ekuedzwa.

Mishonga iyi inotorwa sei?

SGLT2 inhibitors mishonga yemumuromo. Ivo vanowanikwa mune fomu yepiritsi.

Kana chiremba wako achiwedzera SGLT2 inhibitor kuchirongwa chako chekurapa, vanokukurudzira kuti utore kamwe chete kana kaviri pazuva.

Mune zvimwe zviitiko, chiremba wako anogona kupa SGLT2 inhibitor pamwe chete nemimwe mishonga yeshuga. Semuenzaniso, ino kirasi yemishonga inogona kusanganiswa ne metformin.

Musanganiswa weshuga mishonga inogona kukubatsira kuti uchengete huwandu hweshuga yeropa rako mukati mechinangwa chakatarwa. Izvo zvakakosha kutora iyo chaiyo dosi yemushonga wega wega kumisa yako shuga yeropa kubva pakudonha zvakanyanya.

Ndeapi mabhenefiti anogona kutora kutora SGLT2 inhibitor?

Kana uchitorwa uri wega kana nemimwe mishonga yeshuga, SGLT2 inhibitors inogona kubatsira kudzikisa mashuga eropa rako. Izvi zvinoderedza mikana yako yekuvandudza matambudziko kubva kurudzi rwechipiri chirwere cheshuga.

Zvinoenderana neongororo ya2018 yakaburitswa mumagazini Diabetes Care, masayendisiti anoshuma SGLT2 inhibitors inogona zvakare kukurudzira kuonda uye kuvandudza zvine mwero muropa rako uye cholesterol muropa

Ongororo ye2019 yakawana kuti SGLT2 inhibitors yaive yakabatana nenjodzi yakaderera yekurohwa, kurohwa nemoyo, uye kufa kubva kuchirwere chemoyo mune vanhu vane chirwere cheshuga cheshuga uye tsinga dzakaomarara.

Kuongorora kumwechete kwakawana kuti SGLT2 inhibitors inogona kudzora kufambira mberi kwechirwere cheitsvo.

Ramba uchifunga, izvo zvinogona kubatsira zveSGLT2 inhibitors zvinosiyana kubva kune mumwe munhu kuenda kune mumwe, zvinoenderana nezvenhoroondo yavo yekurapa.

Kuti udzidze zvakawanda nezverudzi urwu rwemishonga, uye kana ichi chakaringana chirongwa chako chekurapa, taura nachiremba wako.

Ndedzipi njodzi dzinogona kuitika uye mhedzisiro yekutora mushonga uyu?

SGLT2 inhibitors inowanzoonekwa yakachengeteka, asi mune dzimwe nguva, inogona kukonzera mhedzisiro.

Semuenzaniso, kutora rudzi urwu rwemishonga kunogona kukwidza njodzi yako yekukudziridza:

• Urinary turakiti hutachiona
• zvisina-kutapuriranwa pabonde
• chirwere cheshuga ketoacidosis, izvo zvinoita kuti ropa rako riite acidic
• hypoglycemia, kana shuga shoma yeropa

Muzviitiko zvisingawanzoitika, hutachiona hwakanyanya hwebonde hwakave muvanhu vanotora SGLT2 inhibitors. Rudzi urwu rwehutachiona rwunozivikanwa seinecrotizing fasciitis kana chirwere cheFournier.

Kumwe kutsvagurudza zvakare kunoratidza kuti canagliflozin inogona kuwedzera njodzi yekutyoka kwemapfupa. Iyi mhedzisiro yakaipa haina kubatanidzwa kune dzimwe SGLT2 inhibitors.

Chiremba wako anogona kukuzivisa iwe zvakawanda pamusoro penjodzi dzinogona kuitika dzekutora SGLT2 inhibitors. Vanogona zvakare kukubatsira iwe kudzidza maitiro ekuziva uye kugadzirisa chero angave mhedzisiro mhedzisiro.

Kana iwe uchifunga kuti ungave uri kusangana nemhedzisiro kubva kumishonga, bata chiremba wako ipapo ipapo.

Zvakachengeteka here kusanganisa iyi mhando yemishonga pamwe nezvimwe zvinodhaka?

Chero iwe paunowedzera mushonga mutsva kuchirongwa chako chekurapa, zvakakosha kuti utarise kuti ingabatana sei nemishonga yaunotora kare.

Kana iwe ukatora mimwe mishonga yeshuga kudzikisa huwandu hweshuga yeropa rako, kuwedzera iyo SGLT2 inhibitor inowedzera njodzi yako yekuita shuga yakaderera muropa.

Uye zvakare, kana iwe uri kutora mamwe marudzi eaya diuretics, SGLT2 inhibitors inogona kuwedzera diuretic mhedzisiro yemishonga iyoyo, ichiita kuti iwe uite weti kakawanda. Izvo zvinogona kukwidza njodzi yako yekushaya mvura uye yakaderera BP.

Usati watanga kutora mushonga mutsva kana kuwedzera, bvunza chiremba wako kana ichigona kupindirana nechimwe chinhu muchirongwa chako chekurapa chiripo.

Mune zvimwe zviitiko, chiremba wako anogona kuita shanduko pakurapa kwako kwakatarwa kuti udzikise njodzi yako yekusawirirana kwekushandisa zvinodhaka.

Kutora

SGLT2 inhibitors yakagadzirirwa kubatsira kubata shuga yeropa muvanhu vanorarama nechero 2 chirwere cheshuga.

Kunze kwekudzikisa huwandu hweshuga yeropa, iri kirasi remushonga rakawanikwa riine mabhenefiti emoyo neitsvo. Kunyangwe ivo vachiwanzoonekwa seakachengeteka, SGLT2 inhibitors dzimwe nguva inokonzeresa mhedzisiro kana kusangana kwakashata nemimwe mishonga.

Chiremba wako anogona kukuudza zvakawanda nezve zvingabatsire uye njodzi dzekuwedzera rudzi urwu rwemishonga kuchirongwa chako chekurapa.